Holen Sie sich die Stockscreener-App
8.42
1.08%
0.09
Handel nachbörslich:
8.45
0.03
+0.36%
Schlusskurs vom Vortag:
$8.33
Offen:
$8.4
24-Stunden-Volumen:
7.26M
Relative Volume:
1.15
Marktkapitalisierung:
$1.48B
Einnahmen:
$2.59B
Nettoeinkommen (Verlust:
$-981.73M
KGV:
-1.4593
EPS:
-5.77
Netto-Cashflow:
$206.95M
1W Leistung:
+6.45%
1M Leistung:
+22.03%
6M Leistung:
-14.78%
1J Leistung:
-8.38%
1-Tages-Spanne:
$8.32
$8.71
1-Wochen-Bereich:
$7.69
$8.81
52-Wochen-Spanne:
$6.35
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Firmenname
Teladoc Health Inc
Sektor
Branche
Telefon
(203) 635-2002
Adresse
2 MANHATTANVILLE ROAD, PURCHASE, NY
Vergleichen Sie TDOC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
8.42 | 1.39B | 2.59B | -981.73M | 206.95M | -5.77 |
|
VEEV
Veeva Systems Inc
|
285.20 | 45.64B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
61.08 | 9.68B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
97.41 | 8.32B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
59.38 | 11.63B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
36.57 | 6.57B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-15 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Bestätigt | Jefferies | Hold |
| 2024-02-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-17 | Herabstufung | DA Davidson | Buy → Neutral |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-02-23 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Hochstufung | Guggenheim | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-17 | Herabstufung | Guggenheim | Neutral → Sell |
| 2022-08-12 | Eingeleitet | DA Davidson | Buy |
| 2022-08-02 | Herabstufung | Berenberg | Buy → Hold |
| 2022-08-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-07-28 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-28 | Herabstufung | Needham | Buy → Hold |
| 2022-07-06 | Bestätigt | BofA Securities | Neutral |
| 2022-05-05 | Herabstufung | Argus | Buy → Hold |
| 2022-04-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-28 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-04-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-03 | Hochstufung | Argus | Hold → Buy |
| 2022-02-23 | Bestätigt | BofA Securities | Neutral |
| 2022-02-23 | Bestätigt | Craig Hallum | Hold |
| 2022-02-23 | Bestätigt | Evercore ISI | In-line |
| 2022-02-23 | Bestätigt | Goldman | Buy |
| 2022-02-23 | Bestätigt | JP Morgan | Overweight |
| 2022-02-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Bestätigt | Needham | Buy |
| 2022-02-23 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-08 | Bestätigt | Piper Sandler | Overweight |
| 2021-12-02 | Fortgesetzt | Jefferies | Hold |
| 2021-11-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-28 | Bestätigt | Barclays | Equal Weight |
| 2021-10-28 | Bestätigt | BofA Securities | Neutral |
| 2021-10-28 | Bestätigt | Canaccord Genuity | Buy |
| 2021-10-28 | Bestätigt | Citigroup | Buy |
| 2021-10-28 | Bestätigt | Craig Hallum | Hold |
| 2021-10-28 | Bestätigt | Needham | Buy |
| 2021-10-28 | Bestätigt | Oppenheimer | Outperform |
| 2021-10-28 | Bestätigt | Piper Sandler | Overweight |
| 2021-10-28 | Bestätigt | UBS | Neutral |
| 2021-10-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-08-02 | Herabstufung | Argus | Buy → Hold |
| 2021-07-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-04-15 | Eingeleitet | Needham | Buy |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-12-22 | Eingeleitet | Evercore ISI | In-line |
| 2020-12-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Eingeleitet | Goldman | Neutral |
| 2020-11-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Eingeleitet | DA Davidson | Buy |
| 2020-09-02 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-17 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-07-13 | Eingeleitet | Argus | Buy |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-04-30 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
| 2020-03-25 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-03-16 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Eingeleitet | UBS | Neutral |
| 2020-01-09 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Teladoc Health Inc Aktie (TDOC) Neueste Nachrichten
What drives Teladoc Health Inc. stock priceRapid market gains - jammulinksnews.com
Hims & Hers Paves the Way for Global Digital Health Expansion - Nasdaq
Contrarian Value Investing in Teladoc Health: A Case for Earnings Catalyst Potential Amid Market Doubts - AInvest
Teladoc (TDOC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
Virtual Health Service Market Is Booming So Rapidly 2025-2032Teladoc Health, Amwell, Doctor on Demand, MDLive - openPR.com
Is Teladoc Health Inc. a good long term investmentFree Consultation - jammulinksnews.com
Teladoc Health Inc. Stock Analysis and ForecastSpectacular growth rates - Autocar Professional
What analysts say about Teladoc Health Inc. stockFree Investment Community - Autocar Professional
5 Undervalued AI Stocks Set for a Second-Half 2025 Rebound - AInvest
Lobbying Update: $160,000 of TELADOC HEALTH INC. lobbying was just disclosed - Quiver Quantitative
How Hims & Hers Health Is Quietly Changing Healthcare (NYSE:HIMS) - Seeking Alpha
Teladoc Health’s Turnaround Plan Faces Profit Potholes - Finimize
Teladoc Health Requests to Dismiss Class Action Filed by Investors - TradingView
Can OPRX's Patient Engagement Tools Win Amid Fierce Competition? - Yahoo Finance
Telehealth Services Market Surges on Remote Patient Monitoring - openPR.com
Virtual Hospitalization Solutions Market Future Trend - openPR.com
Teladoc (TDOC) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
Hims & Hers Stock Surges 90.4% in 3 Months: What's Fueling the Rally? - TradingView
Teladoc Health shares rise 3.49% intraday after Mobile-health Network Solutions launched a $300 million ATM equity offering. - AInvest
Distance Health Technology Market Growth Driven - openPR.com
Teladoc Health Inc. to Release Second Quarter 2025 Results and Host Conference Call on July 29 - Quiver Quantitative
Teladoc Health to Announce Second Quarter 2025 Financial Results - GlobeNewswire
Virtual Care Leader Teladoc Health Sets Q2 2025 Earnings Release DateKey Details for Investors - Stock Titan
Lyft to Announce Second Quarter 2025 Financial Results - The Globe and Mail
Teladoc Launches Employee Assistance Program, Expanding Mental Healthcare Offerings - AInvest
Telehealth Heats Up With Teladoc, Livongo Health $18B Merger - PYMNTS.com
Teladoc Health Launches Wellbound Employee Assistance Program - HIT Consultant
CPR Strategic Marketing Communications Highlighted in New Book: Telemedicine Wars, Authored by the Founders of Teladoc - TradingView
AI Telehealth Platform Solutions Market in 2032: A Glimpse Into - openPR.com
Teladoc to launch employee assistance program - Healthcare Dive
Teladoc Health Launches Wellbound Employee Assistance Program to Enhance Workforce Wellness - Nasdaq
Teladoc Health Launches Wellbound Employee Assistance Program (EAP) - GlobeNewswire
Teladoc Revolutionizes Employee Mental Health with New Integrated Wellbound Platform, Partners with BetterHelp - Stock Titan
Unpacking Q1 Earnings: Teladoc (NYSE:TDOC) In The Context Of Other Online Marketplace Stocks - Yahoo Finance
What makes Teladoc Health Inc. stock price move sharplyGrowth Stock Monitor - beatles.ru
Jurisdictional Battles Over Abortion Access: Navigating Regulatory Risks in Healthcare Stocks - AInvest
Patient Support Programs (PSP) Market Growing with - openPR.com
Internet Hospital Market Is Booming So Rapidly By 2032 | Teladoc Health, Amwell, Doctor On Demand, Practo - openPR.com
Digital Mental Health Services Market Is Booming So Rapidly By 2032 | Talkspace, Inc., BetterHelp, Headspace, Inc. - openPR.com
Online Couples Therapy & Counseling Services Market Is Booming - openPR.com
Health Coach Market Is Booming So Rapidly By 2032 | Teladoc Health, Doctor On Demand, MDLIVE - openPR.com
Telemedicine Market Size, Trends, Growth & Global Forecast 2025–2033 - Market Data Forecast
Higgs government initially turned down Teladoc funding ask, records show - Telegraph-Journal
BofA Remains a Hold on Teladoc Health (TDOC), Sets a PT of $8.75 - Yahoo Finance
Teladoc (TDOC): Balancing Strategic Gains with Near-Term Uncertainties in a Volatile Healthcare Landscape - AInvest
Teladoc (TDOC) Dips More Than Broader Market: What You Should Know - Yahoo Finance
Finanzdaten der Teladoc Health Inc-Aktie (TDOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.73%
0.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):